News
Ossiform news and announcements
LSI USA ’26 Emerging Medtech Summit
(February 25, 2026) CEO, Thea Wulff Olesen will be joining strategic partners, leaders, investors, and innovat...
Ossiform® accepted into the ABHI 2026 U.S. Accelerator Program
(February 6, 2026) Ossiform® announces its selection for the ABHI 2026 U.S. Accelerator, a respected program d...
Jackie Fielding joins Ossiform® Board of Directors
Ossiform Ltd. & Ossiform ApS
85 Great Portland Street, London, England, W1W 7LT
Oslogade 1, 5000 Odense,...
Ossiform® obtains ISO 13485 certification
(September 26, 2024, Odense): Ossiform® is pleased to announce that it has obtained the ISO 13485 certificatio...
CELLINK and Ossiform® enter a strategic partnership to launch Ossi Ink, a printable bioink based on Ossiform®’s P3D Bone material
A printable bioink based on Ossiform®’s P3D Bone material
CELLINK and Ossiform® look to capitalize on synerg...
Ossiform and Finnadvance announce partnership
(April 19, 2023) We are thrilled to announce that Finnadvance Ltd. has published a whitepaper in partnership w...
Ossiform® raises new capital
Ossiform® raises capital through West Hill
ODENSE, October 5th, 2022 – Ossiform®, We Print Bone™, is pleased ...
CAM Bioceramics and Ossiform® team up for OMTEC 2022
Ossiform® will be participating at the Orthopedic Manufacturing & Technology Exposition and Conference 202...
Ossiform® – Announces rebrand
Ossiform® - Announces rebrand
ODENSE, January 5th, 2022 - Ossiform®, We Print Bone™, is pleased to announce...
Patent for Ossiform®’s technology granted in China
Chinese Patent Granted for Ossiform®’s 3D printing technology
August 10th 2021, the China National Intellectu...
Ossiform® – New Chairman of the Board
Ossiform® – New market-oriented Chairman of the Board
ODENSE, 1st June 2021 – Ossiform®, We Print Bone™, is p...
Treating mouse skull defects with tricalcium phosphate implants
The performance of 3D printed bone implants in a mouse model of craniectomy
The performance of P3D Bone as a ...